Parkinson's Disease (PD) Background information for medical media outside the US only This selection gives an overview on background material for Parkinson's Disease (PD) available on the Boehringer Ingelheim corporate website.

News Releases

• 14 October 2009Boehringer Ingelheim receives approval from the European Commission for Mirapexin®/Sifrol® prolonged-release, once daily tablet for the treatment of Parkinson’s disease
• 25 August 2008Role of pramipexole in key research areas of Parkinson's disease management discussed at 12th EFNS Congress
• 11 December 2007Pramipexole monotherapy can reduce dyskinesias and delay the need for levodopa treatment in patients with Parkinson's disease
• 28 August 2007PRODEST study shows many Parkinson's disease (PD) patients continue to experience PD-related depressive symptoms despite receiving anti-depressant treatment
• 08 February 2007Multidisciplinary Expert Panel highlights Boehringer Ingelheim's continuing commitment to research in Parkinson's disease
• news release archive

Documents

• Pramipexole - Information sheet - October 2009 - PDF (171 KB)
• Parkison's Disease - Information sheet - October 2009 - PDF (221 KB)
• Pramipexole Prolonged-Release – Information sheet - October 2009 - PDF (163 KB)

Educational website

• 
• PD Knowledge Guide